ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 999,77
0,09%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) Actualités

NVAX

Novavax (NVAX)

Novavax Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DateHeureSourceTitreSymboleSociété
16/05/202403h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/05/202423h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVAXNovavax Inc
13/05/202422h10Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
13/05/202422h02PR Newswire (US)Novavax to Participate in BofA Securities 2024 Health Care ConferenceNASDAQ:NVAXNovavax Inc
13/05/202420h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/05/202414h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
10/05/202414h02IH Market NewsNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More NewsNASDAQ:NVAXNovavax Inc
10/05/202408h15PR Newswire (US)Novavax Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
10/05/202408h00PR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:NVAXNovavax Inc
07/05/202420h43Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NVAXNovavax Inc
07/05/202415h25PR Newswire (US)Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024NASDAQ:NVAXNovavax Inc
07/05/202413h44IH Market NewsTesla’s April Sales Down 18% in China, Amazon’s Multi-Billion Dollar Cloud Expansion in Singapore, and More NewsNASDAQ:NVAXNovavax Inc
06/05/202412h22GlobeNewswire Inc.Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual MeetingNASDAQ:NVAXNovavax Inc
15/04/202412h00GlobeNewswire Inc.Shah Capital nominates two highly qualified independent director candidates for NovavaxNASDAQ:NVAXNovavax Inc
01/04/202414h00PR Newswire (US)Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024NASDAQ:NVAXNovavax Inc
29/02/202422h02PR Newswire (US)Novavax to Participate in TD Cowen's 44th Annual Health Care ConferenceNASDAQ:NVAXNovavax Inc
28/02/202414h00PR Newswire (US)Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
28/02/202413h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVAXNovavax Inc
23/02/202414h03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:NVAXNovavax Inc
22/02/202412h00PR Newswire (US)Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase AgreementNASDAQ:NVAXNovavax Inc
20/02/202415h25PR Newswire (US)Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024NASDAQ:NVAXNovavax Inc
03/01/202415h25PR Newswire (US)Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NVAXNovavax Inc
18/12/202314h00PR Newswire (US)Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in TaiwanNASDAQ:NVAXNovavax Inc
13/12/202323h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
13/12/202314h31Dow Jones NewsModerna Shares, Other Covid Vaccine Makers Hit by Warning From PfizerNASDAQ:NVAXNovavax Inc
13/12/202314h00PR Newswire (Canada)Canadians Can Help Protect Loved Ones as We Head into the Holiday SeasonNASDAQ:NVAXNovavax Inc
05/12/202322h01PR Newswire (Canada)Novavax's Updated COVID-19 Vaccine Now Authorized in CanadaNASDAQ:NVAXNovavax Inc
28/11/202319h13IH Market NewsWall Street Radar: Amazon, Blackrock, General Motors, Eli Lilly, Novavax..NASDAQ:NVAXNovavax Inc
28/11/202312h00PR Newswire (US)Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health OrganizationNASDAQ:NVAXNovavax Inc
17/11/202313h15PR Newswire (US)Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic PrioritiesNASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Dernières Valeurs Consultées

COIN
HMPEUR
BIT
F15162
Vontobel Financial Produ...
COIN
WDTBTC
COIN
FRTUSD
TSXV
PAV
Pacific Arc Resources Ltd.
BITMOT
894001
Cdp Social Bond Tf 0,75%...
ASE
INLOTR
Intralot SA Integrated L...
COIN
NROBTC
USOTC
GRDV
Golden Royal Development (PK)
BIT
GS0263
Goldman Sachs
NASDAQ
BRPAW
Big Rock Partners Acquis...
COIN
KYVEUST
KYVE Network
BFNX
MTNETH
NASDAQ
GOMO
SUNGY MOBILE LTD
USOTC
EKTAF
Elekta B (PK)
LSE
31HB
African Bank20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés